ATRECA INC - A (BCEL) Stock News
NASDAQ:BCEL - Nasdaq - US04965G1094 - Common Stock - Currency: USD
BCEL Latest News, Press Relases and Analysis
Why Is Atreca (BCEL) Stock Up 85% Today?
Atreca stock is heading higher on Thursday as investors react to news of Baker Bros. Advisors LP increasing its stake in the company.
Mentions: MULN
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time for a breakdown of the biggest pre-market stock movers for Wednesday morning as we check out all of the latest news today!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off Tuesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on this morning!
Why Is Clearmind Medicine (CMND) Stock Down 24% Today?
Clearmind Medicine stock is falling on Thursday after shares of CMND underwent a major rally yesterday on a meeting with regulators.
Why Is Tarena International (TCTM) Stock Down 10% Today?
Tarena International stock is slipping on Thursday after the company's shares rallied yesterday with the change to the TCTM ticker.
Why Is Moolec Science (MLEC) Stock Up 40% Today?
Moolec Science stock is on the rise Monday as shares of MLEC see heavy trading despite a lack of news from the food ingredient company.
Mentions: MLEC
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the hottest news this morning!
BCEL Stock Alert: Halper Sadeh LLC Is Investigating Atreca, Inc.
Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome
CAMPBELL, Calif., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Atreca, Inc. (“Atreca”) (NASDAQ: BCEL), a biotechnology company focused on developing novel...
Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome
Mentions: IMNM